Pathfinder Cell Therapy, Inc. (PFND)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2014 | -0.00 USD | 7.41% |
| 2013 | -0.00 USD | 20.59% |
| 2012 | -0.00 USD | 90.56% |
| 2011 | -0.04 USD | -700.0% |
| 2010 | -0.00 USD | 88.94% |
| 2009 | -0.04 USD | 16.43% |
| 2008 | -0.05 USD | 10.31% |
| 2007 | -0.05 USD | -9.7% |
| 2006 | -0.05 USD | -50.0% |
| 2005 | -0.03 USD | 0.0% |
| 2004 | -0.03 USD | 28.1% |
| 2003 | -0.05 USD | 29.38% |
| 2002 | -0.06 USD | -16.7% |
| 2001 | -0.06 USD | -8.79% |
| 2000 | -0.05 USD | 53.45% |
| 1999 | -0.11 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2015 Q2 | -0.00 USD | 20.0% |
| 2015 Q1 | -0.00 USD | 16.67% |
| 2015 Q3 | -0.00 USD | -50.0% |
| 2014 Q3 | -0.00 USD | 0.0% |
| 2014 FY | - USD | 7.41% |
| 2014 Q2 | -0.00 USD | 28.57% |
| 2014 Q4 | -0.00 USD | -20.0% |
| 2014 Q1 | -0.00 USD | 0.0% |
| 2013 Q3 | -0.00 USD | -50.0% |
| 2013 Q4 | -0.00 USD | -16.67% |
| 2013 Q1 | -0.00 USD | -12.5% |
| 2013 Q2 | -0.00 USD | 55.56% |
| 2013 FY | - USD | 20.59% |
| 2012 Q2 | -0.00 USD | -25.0% |
| 2012 Q4 | -0.00 USD | -14.29% |
| 2012 FY | - USD | 90.56% |
| 2012 Q1 | -0.00 USD | -14.29% |
| 2012 Q3 | -0.00 USD | 30.0% |
| 2011 Q3 | -0.02 USD | -2800.0% |
| 2011 Q2 | -0.00 USD | 33.33% |
| 2011 Q1 | -0.00 USD | 18.18% |
| 2011 FY | - USD | -700.0% |
| 2011 Q4 | -0.00 USD | 95.98% |
| 2010 Q3 | -0.00 USD | 76.36% |
| 2010 Q1 | -0.00 USD | 56.1% |
| 2010 Q2 | -0.01 USD | -52.78% |
| 2010 Q4 | -0.00 USD | 15.38% |
| 2010 FY | - USD | 88.94% |
| 2009 Q1 | -0.01 USD | -12.36% |
| 2009 Q3 | -0.01 USD | 8.47% |
| 2009 FY | - USD | 16.43% |
| 2009 Q4 | -0.01 USD | 24.07% |
| 2009 Q2 | -0.01 USD | -18.0% |
| 2008 Q1 | -0.02 USD | -201.79% |
| 2008 Q4 | -0.01 USD | 24.58% |
| 2008 FY | - USD | 10.31% |
| 2008 Q3 | -0.01 USD | -1.72% |
| 2008 Q2 | -0.01 USD | 31.36% |
| 2007 Q4 | -0.01 USD | 63.16% |
| 2007 FY | - USD | -9.7% |
| 2007 Q1 | -0.01 USD | -174.0% |
| 2007 Q2 | -0.02 USD | -45.99% |
| 2007 Q3 | -0.02 USD | 24.0% |
| 2006 Q3 | -0.01 USD | 57.67% |
| 2006 Q4 | -0.01 USD | 45.05% |
| 2006 FY | - USD | -50.0% |
| 2006 Q2 | -0.02 USD | -49.31% |
| 2006 Q1 | -0.01 USD | -200.0% |
| 2005 Q2 | -0.01 USD | -11.76% |
| 2005 Q3 | -0.01 USD | -7.37% |
| 2005 Q4 | -0.00 USD | 52.94% |
| 2005 Q1 | -0.01 USD | -150.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q4 | -0.00 USD | 32.0% |
| 2004 Q2 | -0.01 USD | 44.0% |
| 2004 Q1 | -0.02 USD | -3016.67% |
| 2004 FY | - USD | 28.1% |
| 2004 Q3 | -0.01 USD | 48.98% |
| 2003 Q1 | -0.03 USD | -7.53% |
| 2003 FY | - USD | 29.38% |
| 2003 Q4 | 0.00 USD | 108.96% |
| 2003 Q3 | -0.01 USD | 68.84% |
| 2003 Q2 | -0.02 USD | 28.33% |
| 2002 Q1 | -0.01 USD | -805.0% |
| 2002 FY | - USD | -16.7% |
| 2002 Q2 | -0.01 USD | 14.89% |
| 2002 Q4 | -0.03 USD | -153.64% |
| 2002 Q3 | -0.01 USD | 8.33% |
| 2001 Q4 | 0.00 USD | 128.17% |
| 2001 Q3 | -0.01 USD | 75.35% |
| 2001 Q2 | -0.03 USD | 9.15% |
| 2001 Q1 | -0.03 USD | -258.5% |
| 2001 FY | - USD | -8.79% |
| 2000 Q4 | 0.02 USD | 242.86% |
| 2000 Q1 | -0.03 USD | 0.0% |
| 2000 Q3 | -0.01 USD | 51.72% |
| 2000 Q2 | -0.03 USD | 7.35% |
| 2000 FY | - USD | 53.45% |
| 1999 FY | - USD | 0.0% |